Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Shapiro

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Asia-Pacific Journal of Clinical Oncology|April 19, 2024
A practical guide for the use of apalutamide for non-metastatic castration-resistant prostate cancer in AustraliaGavin Marx, Simon Chowdhury, Laurence Krieger, et al.
Journal of Geriatric Oncology|July 21, 2015
Patterns of care and outcomes for elderly patients with metastatic colorectal cancer in AustraliaSagun Parakh, Hui-Li Wong, Rajat Rai, et al.
Clinical Genitourinary Cancer|February 24, 2024
Carboplatin in Metastatic Castrate Resistant Prostate Cancer: A Retrospective Study of Heavily Pretreated Patients (COMPACT)Lara Pemberton, Connor Allen, Eleanor Handel, et al.
Elife|November 11, 2021
The mitochondrial iron transporter ABCB7 is required for B cell development, proliferation, and class switch recombination in miceMichael Jonathan Lehrke, Michael Jeremy Shapiro, Matthew J Rajcula, et al.
Internal Medicine Journal|June 6, 2022
Compliance with Therapeutic Goods Association prescribing information: weekly or second weekly cetuximab for the treatment of metastatic colorectal cancerMatthew Loft, Jeremy Shapiro, Margaret Lee, et al.
Internal Medicine Journal|October 11, 2020
Use and outcomes of chemotherapy for metastatic pancreatic cancer in AustraliaAmy Body, Rachel Wong, Jeremy Shapiro, et al.
Palliative & Supportive Care|January 3, 2019
Meaning and Purpose (MaP) therapy II: Feasibility and acceptability from a pilot study in advanced cancerDavid W Kissane, Carrie Lethborg, Joanne Brooker, et al.
Internal Medicine Journal|December 8, 2019
Dose modification for haematological toxicity: a survey of Australian medical oncologistsWanyuan Cui, Julia Shingleton, Liesel Byrne, et al.
BMC Health Services Research|February 18, 2022
A qualitative investigation of the supportive care experiences of people living with pancreatic and oesophagogastric cancerNadia N Khan, Ashika Maharaj, Sue Evans, et al.
Elife|December 2, 2021
Histone deacetylase 3 represses cholesterol efflux during CD4<sup>+</sup> T-cell activationDrew Wilfahrt, Rachael L Philips, Jyoti Lama, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Asia-Pacific Journal of Clinical Oncology|April 19, 2024
A practical guide for the use of apalutamide for non-metastatic castration-resistant prostate cancer in AustraliaGavin Marx, Simon Chowdhury, Laurence Krieger, et al.
Journal of Geriatric Oncology|July 21, 2015
Patterns of care and outcomes for elderly patients with metastatic colorectal cancer in AustraliaSagun Parakh, Hui-Li Wong, Rajat Rai, et al.
Clinical Genitourinary Cancer|February 24, 2024
Carboplatin in Metastatic Castrate Resistant Prostate Cancer: A Retrospective Study of Heavily Pretreated Patients (COMPACT)Lara Pemberton, Connor Allen, Eleanor Handel, et al.
Elife|November 11, 2021
The mitochondrial iron transporter ABCB7 is required for B cell development, proliferation, and class switch recombination in miceMichael Jonathan Lehrke, Michael Jeremy Shapiro, Matthew J Rajcula, et al.
Internal Medicine Journal|June 6, 2022
Compliance with Therapeutic Goods Association prescribing information: weekly or second weekly cetuximab for the treatment of metastatic colorectal cancerMatthew Loft, Jeremy Shapiro, Margaret Lee, et al.
Internal Medicine Journal|October 11, 2020
Use and outcomes of chemotherapy for metastatic pancreatic cancer in AustraliaAmy Body, Rachel Wong, Jeremy Shapiro, et al.
Palliative & Supportive Care|January 3, 2019
Meaning and Purpose (MaP) therapy II: Feasibility and acceptability from a pilot study in advanced cancerDavid W Kissane, Carrie Lethborg, Joanne Brooker, et al.
Internal Medicine Journal|December 8, 2019
Dose modification for haematological toxicity: a survey of Australian medical oncologistsWanyuan Cui, Julia Shingleton, Liesel Byrne, et al.
BMC Health Services Research|February 18, 2022
A qualitative investigation of the supportive care experiences of people living with pancreatic and oesophagogastric cancerNadia N Khan, Ashika Maharaj, Sue Evans, et al.
Elife|December 2, 2021
Histone deacetylase 3 represses cholesterol efflux during CD4<sup>+</sup> T-cell activationDrew Wilfahrt, Rachael L Philips, Jyoti Lama, et al.
Pageof 8